Emerging Operating Income from 2010 to 2026
| EWPI Stock | USD 0.0001 0.00 0.00% |
Operating Income | First Reported 2010-12-31 | Previous Quarter -124.7 K | Current Value -131 K | Quarterly Volatility 33.4 K |
Check Emerging World financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emerging World's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 80.1 K or Total Revenue of 0.0, as well as many indicators such as . Emerging financial statements analysis is a perfect complement when working with Emerging World Valuation or Volatility modules.
Emerging | Operating Income | Build AI portfolio with Emerging Stock |
Latest Emerging World's Operating Income Growth Pattern
Below is the plot of the Operating Income of Emerging World Pharma over the last few years. Operating Income is the amount of profit realized from Emerging World Pharma operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Emerging World Pharma is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Emerging World's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Emerging World's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Emerging Operating Income Regression Statistics
| Arithmetic Mean | (129,192) | |
| Coefficient Of Variation | (25.88) | |
| Mean Deviation | 15,692 | |
| Median | (138,592) | |
| Standard Deviation | 33,430 | |
| Sample Variance | 1.1B | |
| Range | 138.3K | |
| R-Value | (0.35) | |
| Mean Square Error | 1B | |
| R-Squared | 0.12 | |
| Significance | 0.17 | |
| Slope | (2,325) | |
| Total Sum of Squares | 17.9B |
Emerging Operating Income History
About Emerging World Financial Statements
Investors use fundamental indicators, such as Emerging World's Operating Income, to determine how well the company is positioned to perform in the future. Although Emerging World's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Operating Income | -124.7 K | -131 K |
Currently Active Assets on Macroaxis
When determining whether Emerging World Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Emerging World's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Emerging World Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Emerging World Pharma Stock:Check out the analysis of Emerging World Correlation against competitors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Drug Manufacturers - Specialty & Generic space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emerging World. If investors know Emerging will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emerging World listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0) |
The market value of Emerging World Pharma is measured differently than its book value, which is the value of Emerging that is recorded on the company's balance sheet. Investors also form their own opinion of Emerging World's value that differs from its market value or its book value, called intrinsic value, which is Emerging World's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emerging World's market value can be influenced by many factors that don't directly affect Emerging World's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emerging World's value and its price as these two are different measures arrived at by different means. Investors typically determine if Emerging World is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emerging World's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.